CIK 0001020214
- Accelerated filer
CERUS CORP
Sign in to watch- Ticker
- CERS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680262011
- Phone
- +1 925-288-6000
- Business address
- 1220 CONCORD AVENUE, SUITE 600, CONCORD, CA, 94520
- 4 Open-market sale President and CEO sold 165,021 shares at an average $5.04 ($831,634)
- 4 Open-market sale Chief Operating Officer sold 41,734 shares at an average $5.04 ($210,320)
- 4 Open-market sale Chief Scientific Officer sold 30,307 shares at $5.04 ($152,735)
- 4 Open-market sale Chief Financial Officer sold 32,102 shares at an average $5.04 ($161,780)
- 4 Open-market sale Chief Medical Officer sold 30,307 shares at $5.04 ($152,735)
- 4 Exercise or conversion Director acquired 5,127 shares (option exercise)
- 4 Grant or award SVP Reg. & Quality acquired 45,000 shares (grant or award)
- 4 Grant or award Chief Legal Officer acquired 52,500 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 90,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 70,000 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 45,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 52,500 shares (grant or award)
- 4 Open-market sale President and CEO sold 308,263 shares at an average $5.70 ($1,757,043)
- 4 Open-market sale SVP Reg. & Quality sold 19,059 shares at $7.00 ($133,417)
- 4 Exercise or conversion Chief Scientific Officer acquired 5,000 shares (option exercise)
- 4 Exercise or conversion Chief Scientific Officer acquired 40,000 shares (option exercise)
- 4 Open-market sale Director sold 25,000 shares at $7.54 ($188,430)
- 4 Open-market sale SVP Reg. & Quality sold 110,000 shares at $7.94 ($873,191)
- 4 Open-market sale Chief Legal Officer sold 40,000 shares at $7.70 ($308,000)
- 4 Open-market sale Chief Financial Officer sold 95,741 shares at $7.00 ($670,187)
Page 8 of 36 · 701 filings